Locations:
Search
Highly personalized treatment shrinks tumors resistant to immunotherapy
Best practices for reducing toxicities
Highlighting treatment gaps and challenges in the management of rare condition
Explaining common misconceptions about chimeric antigen receptor therapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Slower drug elimination from the body among females may impact safety and efficacy
Partnerships with local social service agencies key to program success
Clinicians share practices to streamline initiation of care
Findings may guide future research and personalized treatments
Cleveland Clinic Cancer Institute among select group of centers to administer highly personalized treatment
Real-world results reporting aims to make treatments safer and more effective
Advertisement
Advertisement